SESSION TITLE: Clinical Improvement Posters
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Wednesday, October 30, 2013 at 01:30 PM - 02:30 PM
PURPOSE: Compliance with SAB treatment guidelines and outcomes of patients hospitalized with SAB at our institution
METHODS: We did a retrospective review of all hospitalized patients with SAB between January 2010 and June 2012 at the University of Texas Medical Branch (UTMB). SAB is defined as initial set of positive blood cultures during current hospitalization. Data was collected using RedCap, a web based data collection system. Demographic and clinical data on each patient including compliance with CPG’s guideline was determined. Descriptive statistics is presented as proportions and percents.
RESULTS: A total of 279 patients were hospitalized with SAB during the study period. Of these, 149 (55%) had Methicillin sensitive Staphylococcus aureus (MSSA). On assessing compliance with recommended care, ID consultation was obtained in only 53% of patients, an echocardiographic study was obtained in 63% of patients, and a follow up blood culture was obtained in 82% of patients. The overall mortality was 14%. There was no difference in mortality among patients with MSSA vs MRSA bacteremia (13% vs. 13%). Among patients with a central line at (n= 67) the time of first positive blood cultures, 82 % had the central line removed. Among patients with MRSA bacteremia, the Vancomycin level was therapeutic in 82% (n=85).
CONCLUSIONS: Better outcome of patients with SAB at our institution is likely related to improved compliance with CPG’s.
CLINICAL IMPLICATIONS: Compliance with CPG’s is important in improving outcomes of patients with SAB.
DISCLOSURE: The following authors have nothing to disclose: Sharon Onguti, Won Chung, Philip Keiser, Pinki Patel, Gulshan Sharma
No Product/Research Disclosure Information